Trial Profile
Rosuvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study (TIPS-3)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Coronary artery disease; Myocardial infarction
- Focus Therapeutic Use
- Acronyms TIPS-3
- 24 Jun 2011 New trial record